In newly diagnosed AML patients, serum EVs were enriched in myeloblastic markers important for AML diagnosis (CD33, CD34, and CD117), as well as in essential proteins, such as genes related to MHC class I and TGFβ1 [34]. This evidence concerns the gene TGFB1 and acute myeloid leukemia.